EUVIMEDEUVIMED entdecken
Leitlinie

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid und 47 weitere

Hepatology International · 2025-04 · 19 (2) · 261-301

DOI: 10.1007/s12072-024-10774-3 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Hepatology International, online erschienen am 27.02.2025. Verfasst von Mohammed Eslam und 58 weiteren Autor:innen. Beteiligte Einrichtung: Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, 2145, Australia. mohammed.esl…. Hauptthemen laut MEDLINE: Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 188-mal zitiert (Crossref) und nennt 415 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused on MAFLD. The guidelines cover various aspects of the disease, such as its epidemiology, diagnosis, screening, assessment, and treatment. The guidelines aim to advance clinical practice, knowledge, and research on MAFLD, particularly in special groups. The guidelines are designed to advance clinical practice, to provide evidence-based recommendations to assist healthcare stakeholders in decision-making and to improve patient care and disease awareness. The guidelines take into account the burden of clinical management for the healthcare sector.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverNon-alcoholic Fatty Liver DiseaseHumans

Autor:innen und Institutionen

  • Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, 2145, Australia. mohammed.eslam@sydney.edu.au.
  • Center for Fatty Liver, Department of Gastroenterology, Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hepatobiliary Division, Department of Internal MedicineCollege of Medicine and Center for Liquid Biopsy and Cohort ResearchFaculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medic…
  • Medical Data Analytics Centre, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China.
  • Institute of Digestive and Liver Diseases, St. Luke's Medical Center, Global City, Philippines.
  • Division of Gastroenterology and Hepatology, Department of Internal MedicineHepatitis Research CenterGraduate Institute of Clinical Medicine, National Taiwan University Hospital, National Taiwan University College of Me…

Zitieren

APA

Eslam, M., Fan, J. G., Yu, M. L., Wong, V. W., Cua, I. H., Liu, C. J., Tanwandee, T., Gani, R., Seto, W. K., Alam, S., Young, D. Y., Hamid, S., Zheng, M. H., Kawaguchi, T., Chan, W. K., Payawal, D., Tan, S. S., Goh, G. B., Strasser, S. I., …, & George, J. (2025). The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatology International, 19(2), 261-301. https://doi.org/10.1007/s12072-024-10774-3

Vancouver

Eslam M, Fan JG, Yu ML, Wong VW, Cua IH, Liu CJ, et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatology International. 2025;19(2):261-301. doi:10.1007/s12072-024-10774-3

BibTeX
@article{Eslam2025,
  author = {Eslam, Mohammed and Fan, Jian-Gao and Yu, Ming-Lung and Wong, Vincent Wai-Sun and Cua, Ian Homer and Liu, Chun-Jen and Tanwandee, Tawesak and Gani, Rino and Seto, Wai-Kay and Alam, Shahinul and Young, Dan Yock and Hamid, Saeed and Zheng, Ming-Hua and Kawaguchi, Takumi and Chan, Wah-Kheong and Payawal, Diana and Tan, Soek-Siam and Goh, George Boon-Bee and Strasser, Simone I and Viet, Hang Dao and Kao, Jia-Horng and Kim, Won and Kim, Seung Up and Keating, Shelley E and Yilmaz, Yusuf and Kamani, Lubna and Wang, Chia-Chi and Fouad, Yasser and Abbas, Zaigham and Treeprasertsuk, Sombat and Thanapirom, Kessarin and Al Mahtab, Mamun and Lkhagvaa, Undram and Baatarkhuu, Oidov and Choudhury, Ashok Kumar and Stedman, Catherine A M and Chowdhury, Abhijit and Dokmeci, A Kadir and Wang, Fu-Sheng and Lin, Han-Chieh and Huang, Jee-Fu and Howell, Jess and Jia, Jidong and Alboraie, Mohamed and Roberts, Stuart K and Yoneda, Masato and Ghazinian, Hasmik and Mirijanyan, Aram and Nan, Yuemin and Lesmana, Cosmas Rinaldi Adithya and Adams, Leon A and Shiha, Gamal and Kumar, Manoj and Örmeci, Necati and Wei, Lai and Lau, George and Omata, Masao and Sarin, Shiv K and George, Jacob},
  title = {The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease},
  journal = {Hepatology International},
  year = {2025},
  volume = {19},
  number = {2},
  pages = {261--301},
  doi = {10.1007/s12072-024-10774-3}
}
Kostenlos starten →